Journal Papers, Abstracts, and Commentaries
| |
High hepatitis C incidence in relation to prescription opioid
injection and poly-drug use: Assessing barriers to hepatitis C prevention.
Puzhko S, Roy É, Jutras-Aswad D, et a
l Int
J Drug Policy. 2017 Jun 27
Abstract
Visualizing harm reduction: Methodological and ethical considerations.
Switzer S, Guta A, de Prinse K, et al
Soc Sci Med. 2015 Mar
19;133:77-84.
Abstract
Willingness to access an in-hospital supervised injection
facility among hospitalized people who use illicit drugs.
Ti L, Buxton J, Harrison S, Dobrer
S, et al
J Hosp Med. 2015 Mar 5.
Abstract
Peer helpers' struggles to care for "others" who inject
drugs.
Dechman MK.
Int J Drug Policy. 2015 Jan 8.
Abstract
FULL-TEXT
ARTICLE
A cost-benefit/cost-effectiveness analysis of
proposed supervised injection facilities in Ottawa, Canada.
Jozaghi E, Reid AA, Andresen MA, Juneau A.
Subst Abuse Treat Prev Policy. 2014 Aug 4;9(1):31
Paper
Use of a Medically Supervised Injection Facility Among
Street Youth.
Hadland SE, DeBeck K, Kerr T, et al
J Adolesc Health. 2014 Jun 9.
Abstract
Patterns of injection drug use cessation during an
expansion of syringe exchange services in a Canadian setting.
Werb D, Kerr T, Buxton J, et al
Drug Alcohol Depend.
2013 May 1
Abstract
FULL-TEXT PDF ARTICLE
'On the
same level': facilitators' experiences running a drug user-led safer
injecting education campaign.
Callon C, Charles G, Alexander R, Small W, Kerr T.
Harm Reduct J. 2013 Mar
6;10:4.
Paper |
Needle exchange and the HIV epidemic in
Vancouver: Lessons learned from 15 years of research.
Hyshka E, Strathdee S, Wood E, Kerr T.
Int J
Drug
Policy.
2012 May 10.
Abstract |
HIV treatment as prevention among injection drug users.
Wood E, Milloy MJ, Montaner JS.
Curr Opin HIV AIDS.
2012 Mar;7(2):151-6.
Abstract |
The Growing Popularity of Prescription Opioid Injection in Downtown Montreal:
New Challenges for
Harm Reduction.
Roy L, Arruda N, Bourgois P.
Subst Use Misuse. 2011 Mar 3
Abstract
Needle exchange as a safe haven in an unsafe world.
Macneil J, Pauly B.
Drug Alcohol Rev.
2011 Jan;30(1):26-32
Abstract |
Toward a Comprehensive Approach to HIV Prevention for People Who Use Drugs.
Marshall BD, Wood E
J Acquir Immune Defic Syndr. 2010 Dec
1;55 Suppl 1:S23-6.
Abstract |
IDU Perspectives on the Design and Operation of North America's First
Medically
Supervised
Injection Facility.
Small W, Ainsworth L, Wood E, Kerr T.
Subst Use Misuse. 2010 Sep 27
Abstract |
An external evaluation of a peer-run outreach-based syringe
exchange in
Vancouver, Canada.
Hayashi K, Wood E, Wiebe L, Qi J, Kerr T.
I
nt J Drug Policy. 2010 Mar 30.
Abstract |
|
|
|
|
|
Conference Reports, Abstracts, and Posters
| |
On point: making prison-based needle and syringe
programs work in Canada
S.K.H. Chu, S. Clarke, J. Danforth, et al
(XX International AIDS
Conference)
Abstract
Acceptability of
HIV pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID) in
Vancouver, Canada
D. Escudero, T. Kerr, E. Wood, et al
(XX International AIDS
Conference)
Abstract
Estimating the number of HIV and hepatitis C cases
averted through the implementation of federal prison-based needle exchange
programs in Canada
D. Werb
(XX International AIDS
Conference)
Abstract
Safe cells: building the case for prison-based needle
and syringe programs in Canada
S.K.H. Chu1 S. Clarke, R. Elliott, et al
(XIX International AIDS
Conference)
Abstract
The
legal fight for harm reduction: the use of empirical and social science data
to establish legal rights to safe injection
S. Bernstein, K. Pacey
(XIX International AIDS
Conference)
Abstract
|
|
|
|
Iceland
United
States
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader